Among AYAs with breast cancer, short-term survival varied by breast cancer subtypes, with AYAs diagnosed with HR-/HER2+ and triple-negative breast cancer experiencing poorer short-term survival than AYAs diagnosed with HR+/HER2- breast cancer. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.